247 related articles for article (PubMed ID: 16294902)
1. Tumor control probability (TCP) and normal tissue complication probability (NTCP) in head and neck cancer.
Grégoire V
Rays; 2005; 30(2):105-8. PubMed ID: 16294902
[TBL] [Abstract][Full Text] [Related]
2. TCP and NTCP: a basic introduction.
Baumann M; Petersen C
Rays; 2005; 30(2):99-104. PubMed ID: 16294901
[TBL] [Abstract][Full Text] [Related]
3. Advances in radiotherapy for carcinoma of the head and neck.
Morris MM; Schmidt-Ullrich R; Johnson CR
Surg Oncol Clin N Am; 2000 Jul; 9(3):563-75, x. PubMed ID: 10853142
[TBL] [Abstract][Full Text] [Related]
4. Clinical assessment of outcome of prostate cancer (TCP, NTCP).
Perez CA; Michalski J; Mansur D
Rays; 2005; 30(2):109-20. PubMed ID: 16294903
[TBL] [Abstract][Full Text] [Related]
5. TCP and NTCP in preclinical and clinical research in Europe.
Baumann M; Petersen C; Krause M
Rays; 2005; 30(2):121-6. PubMed ID: 16294904
[TBL] [Abstract][Full Text] [Related]
6. CalcNTCP: a simple tool for computation of normal tissue complication probability (NTCP) associated with cancer radiotherapy.
Khan HA
Int J Radiat Biol; 2007 Oct; 83(10):717-20. PubMed ID: 17729166
[TBL] [Abstract][Full Text] [Related]
7. Comparison of traditional and simultaneous IMRT boost technique basing on therapeutic gain calculation.
Slosarek K; Zajusz A; Szlag M
Med Dosim; 2008; 33(4):299-302. PubMed ID: 18973858
[TBL] [Abstract][Full Text] [Related]
8. Impact of dose and volume on radiation-induced mucositis.
Mantini G; Manfrida S; Cellini F; Giammarino D; Petrone A; Vitucci P; Cellini N
Rays; 2005; 30(2):137-44. PubMed ID: 16294906
[TBL] [Abstract][Full Text] [Related]
9. Effect of Cisplatin on parotid gland function in concomitant radiochemotherapy.
Hey J; Setz J; Gerlach R; Vordermark D; Gernhardt CR; Kuhnt T
Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1475-80. PubMed ID: 19515505
[TBL] [Abstract][Full Text] [Related]
10. Three-dimensional conformal radiotherapy for locally advanced (Stage II and worse) head-and-neck cancer: dosimetric and clinical evaluation.
Portaluri M; Fucilli FI; Castagna R; Bambace S; Pili G; Tramacere F; Russo D; Francavilla MC
Int J Radiat Oncol Biol Phys; 2006 Nov; 66(4):1036-43. PubMed ID: 16750321
[TBL] [Abstract][Full Text] [Related]
11. Large cohort dose-volume response analysis of parotid gland function after radiotherapy: intensity-modulated versus conventional radiotherapy.
Dijkema T; Terhaard CH; Roesink JM; Braam PM; van Gils CH; Moerland MA; Raaijmakers CP
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(4):1101-9. PubMed ID: 18472355
[TBL] [Abstract][Full Text] [Related]
12. Preoperative radiation treatment for rectal cancer: comparison of target coverage and small bowel NTCP in conventional vs. 3D-conformal planning.
Cella L; Ciscognetti N; Martin G; Liuzzi R; Punzo G; Solla R; Farella A; Salvatore M; Pacelli R
Med Dosim; 2009; 34(1):75-81. PubMed ID: 19181259
[TBL] [Abstract][Full Text] [Related]
13. The use of spatial dose gradients and probability density function to evaluate the effect of internal organ motion for prostate IMRT treatment planning.
Jiang R; Barnett RB; Chow JC; Chen JZ
Phys Med Biol; 2007 Mar; 52(5):1469-84. PubMed ID: 17301465
[TBL] [Abstract][Full Text] [Related]
14. Future issues in highly conformal radiotherapy for head and neck cancer.
Feng M; Eisbruch A
J Clin Oncol; 2007 Mar; 25(8):1009-13. PubMed ID: 17350951
[TBL] [Abstract][Full Text] [Related]
15. A simple method to calculate the influence of dose inhomogeneity and fractionation in normal tissue complication probability evaluation.
Begnozzi L; Gentile FP; Di Nallo AM; Chiatti L; Zicari C; Consorti R; Benassi M
Strahlenther Onkol; 1994 Oct; 170(10):590-4. PubMed ID: 7974170
[TBL] [Abstract][Full Text] [Related]
16. Radiobiological predictors of tumor and acute normal tissue response in radiotherapy for head and neck cancers.
Maciejewski B; Skladowski K; Zajusz A
Neoplasma; 1991; 38(5):513-22. PubMed ID: 1956467
[TBL] [Abstract][Full Text] [Related]
17. Outcomes of visual acuity in carbon ion radiotherapy: analysis of dose-volume histograms and prognostic factors.
Hasegawa A; Mizoe JE; Mizota A; Tsujii H
Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):396-401. PubMed ID: 16182466
[TBL] [Abstract][Full Text] [Related]
18. IMRT dose fractionation for head and neck cancer: variation in current approaches will make standardisation difficult.
Ho KF; Fowler JF; Sykes AJ; Yap BK; Lee LW; Slevin NJ
Acta Oncol; 2009; 48(3):431-9. PubMed ID: 18781445
[TBL] [Abstract][Full Text] [Related]
19. Dose painting: art or science?
Tanderup K; Olsen DR; Grau C
Radiother Oncol; 2006 Jun; 79(3):245-8. PubMed ID: 16725221
[No Abstract] [Full Text] [Related]
20. [Constraints to organs at risk for treatment of head and neck cancers by intensity modulated radiation therapy].
Maingon P; Mammar V; Peignaux K; Truc G; Barillot I
Cancer Radiother; 2004 Aug; 8(4):234-47. PubMed ID: 15450517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
